13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001420995
Total reported value
$467.8M
$467.8M
8 檔
140.0%
The Q3 2025 SEC filing reveals that Trustees of Columbia University in the City of New York held a total portfolio value of $467.8M, covering 8 public equity positions.
In Q3 2025, Trustees of Columbia University in the City of New York adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 4 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including SPY, SRZN, TNYA) accounted for 140.0% of total reported equity market value during Q3 2025.
Top New Position Initiated
RAPT
市值: $236.5K
Top Position Liquidated / Trimmed
NU
前期市值: $9.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 99.69% | -1.24% | -11.87% | |
| 2 | SRZN | Surrozen Inc | Stock-Other | 0.09% | — | — | |
| 3 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.07% | — | — | |
| 4 | QTTB | Q32 Bio Inc | Stock-Other | 0.04% | — | — | |
| 5 | RAPT | Rapt Therapeutics Inc | Stock-Other | 0.04% | — | — | |
| 6 | VOR | Vor Biopharma Inc | Stock-Other | 0.03% | — | — | |
| 7 | ✓ | Xilio Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 8 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +1.4% | -11.87% | Trim |
| 2 | TNYA | Tenaya Therapeutics Inc | 0% | — | Unchanged |
| 3 | SRZN | Surrozen Inc | — | — | Unchanged |
| 4 | QTTB | Q32 Bio Inc | — | — | Unchanged |
| 5 | ✓ | Xilio Therapeutics Inc | — | — | Unchanged |
| 6 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 7 | NU | Nu Holdings Ltd. | — | EXIT | Sold out |
| 8 | VIGL | Vigil Neuroscience Inc | — | EXIT | Sold out |
| 9 | RAPT | Rapt Therapeutics Inc | — | NEW | New buy |
| 10 | VOR | Vor Biopharma Inc | — | NEW | New buy |
| 11 | ✓ | Rapt Therapeutics Inc | — | EXIT | Sold out |
| 12 | VOR | Vor Biopharma Inc. | — | EXIT | Sold out |
According to official SEC Form 13F filings, Trustees of Columbia University in the City of New York reported a total U.S. public equity portfolio value of $467.8M across 8 disclosed positions in Q3 2025.
During Q3 2025, Trustees of Columbia University in the City of New York's top holdings by market value included SPY (99.7%)、SRZN (0.1%)、TNYA (0.1%). The largest single position, SPY, represented 99.7% of total portfolio value.
In Q3 2025, Trustees of Columbia University in the City of New York made 7 total portfolio adjustments, initiating 2 new buys, adding to 0 positions, trimming 1 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.